Utah Medical Products (UTMD): What Does the Company Do? – Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
Utah Medical Products (UTMD) is a U.S. micro-cap medical device company specializing in women's health, obstetrics/gynecology, and neonatal care, known for stable margins, solid cash flow, and consistent capital returns. Here are the key points on UTMD's stock price, earnings, and related stocks.
🏢 What kind of company is Utah Medical Products?
Utah Medical Products is a specialized medical device manufacturer focused on women's health and neonatal care. Headquartered in the United States, the company has designed and produced clinical devices in obstetrics/gynecology, neonatal care, and blood pressure monitoring for more than 40 years, with its long-standing position in a niche market defining its identity.
Its core business is the manufacture of disposable and reusable medical devices and components for obstetrics/gynecology and neonatal care. The company sells its proprietary-branded devices directly to medical institutions while also running a contract manufacturing business that supplies components and finished products to other companies, establishing itself as a trusted supplier in its specialty area.
How does Utah Medical Products make money?| Business Segment | Revenue Share | Description |
|---|---|---|
| Direct Device Sales | Core | Direct supply of women's health and obstetrics/gynecology devices to medical institutions |
| Filshie Device | Key Growth Driver | Direct sales of proprietary-branded devices, including contraceptive clips |
Revenue is largely driven by direct sales of proprietary-branded medical devices, with women's health devices serving as the main pillar of its domestic direct sales. Contract manufacturing (OEM) component supply is added on top, diversifying income sources. The business is characterized by a stable margin structure built on precision manufacturing know-how, and given the niche-market nature where clinical reliability is highly valued, the company defends profitability through design and quality differentiation rather than price competition. The complementary effect between business segments reduces dependence on any single product, contributing to stability.
📐 Utah Medical Products Market Cap and Company Size
Market capitalization stands at $221.9M, with 183 people employees.
Utah Medical Products is a specialized manufacturer classified as a micro-cap within the medical device industry. Unlike large diversified medical device companies, it concentrates on a narrow area—women's health and neonatal care—to secure its position in a niche market. A notable feature is its steady execution of capital returns, including dividends and share buybacks, supported by solid cash flow.
📈 Utah Medical Products Outlook and Stock Price Trends
In the short term, hospital and medical institution procedure volumes, inventory adjustments, and exchange rate fluctuations may act as variables in revenue flow. Over the medium to long term, structural growth in aging demographics and demand for women's health and neonatal care underpins the business foundation. Precision manufacturing capabilities and the contract manufacturing customer base serve as stable growth drivers. However, given the business structure's focus on a narrow product lineup, demand softness in specific product categories or changes in the regulatory environment remain potential volatility factors.
- Growth in women's health and neonatal care demand
- Expansion of the contract manufacturing customer base
⚔️ Utah Medical Products Core Competitive Strengths and Risks
Niche market positioning based on clinical credibility and stable cash flow are strengths, while concentration in a narrow product lineup and limited market size represent risks.
💪 Core Competitive Strengths
⚠️ Core Risks
🔄 Utah Medical Products Competitors and Related (Beneficiary) Stocks
Utah Medical Products competes with diversified large-cap companies in the specialty medical device space. In terms of direct competition, TFX, which covers obstetrics/gynecology, neonatal, and critical care devices, and CNMD, which focuses on surgical medical devices, are comparable within the same medical device sector. Related stocks include diversified medical device makers ABT and MDT, which are grouped together as names that move with broader industry trends.
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| Teleflex Incorporated | $130.99 | -0.8% | $5.6B | - | 1.9 | -10.51% | 0.87% | |
| Conmed Corp | $46.30 | +0.2% | $1.4B | 25.0 | 1.3 | 5.53% | 0.43% |
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $101.95 | -1.4% | $176.4B | 33.0 | 3.5 | 10.63% | 2.53% |
| MDT | Medtronic Plc | $90.96 | -0.7% | $116.4B | 22.4 | 2.3 | 10.66% | 3.18% |
✅ Utah Medical Products Investor Checkpoints
When evaluating Utah Medical Products, it is important to understand the characteristics of its narrow, specialized business structure. As a company whose strengths lie more in stable profitability and capital returns than in top-line growth, both business momentum and financial soundness should be reviewed together.
| Checkpoint | What to Verify | Current Status |
|---|---|---|
| 📈 Business Momentum | Revenue trends across direct sales and contract manufacturing | Stable flow maintained |
| 💵 Financial Soundness | Profitability and cash flow metrics | Healthy margin levels maintained |
| 💰 Capital Returns | Dividend and share buyback policy | Ongoing |
| 🌍 Macro & Industry Variables | Medical institution demand and FX exposure | Worth monitoring |
The core risk is the business structure's concentration in a narrow product lineup. If demand in a specific area weakens or the regulatory environment changes, revenue volatility could increase. The existence of a ceiling on top-line growth, given the niche market nature, should also be factored in.
Utah Medical Products is a micro-cap medical device company that has demonstrated stable profitability and consistent capital returns in the specialty area of women's health and neonatal care. As a name that prioritizes solidity over flashy growth, a long-term approach that takes into account the characteristics of its business structure is recommended.